Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma.

Battistello E, Katanayeva N, Dheilly E, Tavernari D, Donaldson MC, Bonsignore L, Thome M, Christie AL, Murakami MA, Michielin O, Ciriello G, Zoete V, Oricchio E.

Blood. 2018 May 24;131(21):2345-2356. doi: 10.1182/blood-2017-10-809210. Epub 2018 Mar 22.

2.

Sestrin1, a tumor suppressor that can be rescued.

Donaldson MC, Katanayeva N, Oricchio E.

Mol Cell Oncol. 2017 Sep 21;4(6):e1365107. doi: 10.1080/23723556.2017.1365107. eCollection 2017.

PMID:
29209652
3.

Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies.

Mina M, Raynaud F, Tavernari D, Battistello E, Sungalee S, Saghafinia S, Laessle T, Sanchez-Vega F, Schultz N, Oricchio E, Ciriello G.

Cancer Cell. 2017 Aug 14;32(2):155-168.e6. doi: 10.1016/j.ccell.2017.06.010. Epub 2017 Jul 27.

4.

Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.

Oricchio E, Katanayeva N, Donaldson MC, Sungalee S, Pasion JP, Béguelin W, Battistello E, Sanghvi VR, Jiang M, Jiang Y, Teater M, Parmigiani A, Budanov AV, Chan FC, Shah SP, Kridel R, Melnick AM, Ciriello G, Wendel HG.

Sci Transl Med. 2017 Jun 28;9(396). pii: eaak9969. doi: 10.1126/scitranslmed.aak9969.

5.

Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Boice M, Salloum D, Mourcin F, Sanghvi V, Amin R, Oricchio E, Jiang M, Mottok A, Denis-Lagache N, Ciriello G, Tam W, Teruya-Feldstein J, de Stanchina E, Chan WC, Malek SN, Ennishi D, Brentjens RJ, Gascoyne RD, Cogné M, Tarte K, Wendel HG.

Cell. 2016 Oct 6;167(2):405-418.e13. doi: 10.1016/j.cell.2016.08.032. Epub 2016 Sep 29.

6.

Generation and characterization of a single-chain anti-EphA2 antibody.

Goldgur Y, Susi P, Karelehto E, Sanmark H, Lamminmäki U, Oricchio E, Wendel HG, Nikolov DB, Himanen JP.

Growth Factors. 2014 Dec;32(6):214-22. doi: 10.3109/08977194.2014.983225. Epub 2014 Nov 19.

7.

A cell engineering strategy to enhance the safety of stem cell therapies.

Oricchio E, Papapetrou EP, Lafaille F, Ganat YM, Kriks S, Ortega-Molina A, Mark WH, Teruya-Feldstein J, Huse JT, Reuter V, Sadelain M, Studer L, Wendel HG.

Cell Rep. 2014 Sep 25;8(6):1677-1685. doi: 10.1016/j.celrep.2014.08.039. Epub 2014 Sep 18.

8.

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.

Oricchio E, Ciriello G, Jiang M, Boice MH, Schatz JH, Heguy A, Viale A, de Stanchina E, Teruya-Feldstein J, Bouska A, McKeithan T, Sander C, Tam W, Seshan VE, Chan WC, Chaganti RS, Wendel HG.

J Exp Med. 2014 Jun 30;211(7):1379-91. doi: 10.1084/jem.20132120. Epub 2014 Jun 9.

9.

Functional genomics lead to new therapies in follicular lymphoma.

Oricchio E, Wendel HG.

Ann N Y Acad Sci. 2013 Jul;1293:18-24. doi: 10.1111/nyas.12120. Epub 2013 May 15. Review.

10.

Progress against follicular lymphoma.

Schatz JH, Oricchio E, Puvvada SD, Wendel HG.

Curr Opin Hematol. 2013 Jul;20(4):320-6. doi: 10.1097/MOH.0b013e3283622ed6. Review.

11.

Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma.

Oricchio E, Wendel HG.

Cell Cycle. 2012 Mar 15;11(6):1076-80. doi: 10.4161/cc.11.6.19451. Epub 2012 Mar 15.

12.

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.

Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen AB, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RS, Wendel HG.

Cell. 2011 Oct 28;147(3):554-64. doi: 10.1016/j.cell.2011.09.035.

13.

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma.

Schatz JH, Oricchio E, Wolfe AL, Jiang M, Linkov I, Maragulia J, Shi W, Zhang Z, Rajasekhar VK, Pagano NC, Porco JA Jr, Teruya-Feldstein J, Rosen N, Zelenetz AD, Pelletier J, Wendel HG.

J Exp Med. 2011 Aug 29;208(9):1799-807. doi: 10.1084/jem.20110846. Epub 2011 Aug 22.

14.

Mouse models of cancer as biological filters for complex genomic data.

Oricchio E, Wolfe AL, Schatz JH, Mavrakis KJ, Wendel HG.

Dis Model Mech. 2010 Nov-Dec;3(11-12):701-4. doi: 10.1242/dmm.006296. Epub 2010 Sep 27.

15.

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, Parker JS, Paddison PJ, Tam W, Ferrando A, Wendel HG.

Nat Cell Biol. 2010 Apr;12(4):372-9. doi: 10.1038/ncb2037. Epub 2010 Feb 28.

16.

The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation.

Serafino A, Balestrieri E, Pierimarchi P, Matteucci C, Moroni G, Oricchio E, Rasi G, Mastino A, Spadafora C, Garaci E, Vallebona PS.

Exp Cell Res. 2009 Mar 10;315(5):849-62. doi: 10.1016/j.yexcr.2008.12.023. Epub 2009 Jan 8.

PMID:
19167380
17.

Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines.

Bonaccorsi I, Altieri F, Sciamanna I, Oricchio E, Grillo C, Contartese G, Galati EM.

Cancer Lett. 2008 May 8;263(1):130-9. doi: 10.1016/j.canlet.2007.12.026. Epub 2008 Feb 20.

PMID:
18282657
18.

Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.

Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C.

Oncogene. 2007 Jun 21;26(29):4226-33. Epub 2007 Jan 22.

PMID:
17237820
19.

ATM is activated by default in mitosis, localizes at centrosomes and monitors mitotic spindle integrity.

Oricchio E, Saladino C, Iacovelli S, Soddu S, Cundari E.

Cell Cycle. 2006 Jan;5(1):88-92. Epub 2006 Jan 21.

PMID:
16319535
20.

p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation.

Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, Lavia P, Soddu S, Cundari E.

Mol Biol Cell. 2004 Aug;15(8):3751-7. Epub 2004 Jun 4.

Supplemental Content

Loading ...
Support Center